AN2 Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACRV
|
Acrivon Therapeutics, Inc. Common Stock | $7.33 | $223.86 M | -2.51 | 58 | $0 |
 ADAG
|
Adagene Inc. | $2.35 | $131.46 M | -6.77 | 174 | $18.11 M |
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.44 | $56.28 M | -5.86 | 2 | $0 |
 AVTE
|
Aerovate Therapeutics, Inc. | $2.61 | $597.48 M | -6.84 | 51 | $0 |
 ELYM
|
Eliem Therapeutics, Inc. | $5.11 | $258.33 M | -17.08 | 9 | $0 |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.82 | $652.38 M | -6.03 | 28 | $0 |
 MNOV
|
MediciNova, Inc. | $2.32 | $67.19 M | -8.06 | 13 | $1.00 M |
 MOLN
|
Molecular Partners AG | $5.60 | $135.05 M | -2.03 | 167 | $7.04 M |
 PEPG
|
PepGen Inc. | $6.64 | $537.15 M | -5.11 | 76 | $0 |
 PHVS
|
Pharvaris N.V. | $19.97 | $843.31 M | -5.8 | 83 | $0 |
 PMVP
|
PMV Pharmaceuticals, Inc. | $1.66 | $85.40 M | -1.26 | 63 | $0 |
 RZLT
|
Rezolute, Inc. | $5.38 | $229.57 M | -5.02 | 59 | $0 |